2018 update on dermatologic laser therapy: Part 1 – epilation, vascular lesions and pigments
Corresponding Author
Uwe Paasch
Department of Dermatology, Venereology and Allergology, Leipzig University Medical Center, and Medical Faculty, Leipzig University, Leipzig, Germany
Correspondence to
Prof. Dr. med. habil. Uwe Paasch
Department of Dermatology, Venereology and Allergology
Leipzig University Medical Center
Philipp-Rosenthal-Straße 23
04103 Leipzig, Germany
E-mail: [email protected]
Search for more papers by this authorSonja Grunewald
Department of Dermatology, Venereology and Allergology, Leipzig University Medical Center, and Medical Faculty, Leipzig University, Leipzig, Germany
Search for more papers by this authorCorresponding Author
Uwe Paasch
Department of Dermatology, Venereology and Allergology, Leipzig University Medical Center, and Medical Faculty, Leipzig University, Leipzig, Germany
Correspondence to
Prof. Dr. med. habil. Uwe Paasch
Department of Dermatology, Venereology and Allergology
Leipzig University Medical Center
Philipp-Rosenthal-Straße 23
04103 Leipzig, Germany
E-mail: [email protected]
Search for more papers by this authorSonja Grunewald
Department of Dermatology, Venereology and Allergology, Leipzig University Medical Center, and Medical Faculty, Leipzig University, Leipzig, Germany
Search for more papers by this authorSummary
Technical advances in recent years have led to new dermatologic laser systems, light sources, and treatment concepts. Commonly used wavelengths – generated today with LED-based devices – allow for the combination of various tissue effects and are associated with improved outcomes. Laser hair removal has become more efficient with the use of diode lasers that emit multiple wavelengths simultaneously. In the near future, novel LED-based lasers will also be introduced for the treatment of vascular lesions. Here, too, the combination of different wavelengths promises to be beneficial. Picosecond lasers have led to advances in the field of pigment removal (tattoos).
Conflict of Interest
None.
References
- 1Grunewald S, Bodendorf MO, Simon JC, Paasch U. Update dermatologic laser therapy. J. Dtsch Dermatol Ges 2011; 9: 146–59.
- 2Paasch U, Wagner JA, Paasch HW. Novel 755-nm diode laser vs. conventional 755-nm scanned alexandrite laser: Side-by-side comparison pilot study for thorax and axillary hair removal. J Cosmet Laser Ther 2015; 17: 189–93.
- 3Paasch U, Schwandt A, Seeber N et al. New lasers and light sources – old and new risks? J Dtsch Dermatol Ges 2017; 15: 487–96.
- 4Zelickson Z, Schram S, Zelickson B. Complications in cosmetic laser surgery: a review of 494 Food and Drug Administration Manufacturer and User Facility Device Experience Reports. Dermatol Surg 2014; 40: 378–82.
- 5Hussain M, Polnikorn N, Goldberg DJ. Laser-assisted hair removal in Asian skin: efficacy, complications, and the effect of single versus multiple treatments. Dermatol Surg 2003; 29: 249–54.
- 6Goldberg D. Laser complications: hair removal. J Cosmet Laser Ther 2006; 8: 197–202.
- 7Vano-Galvan S, Jaen P. Complications of nonphysician-supervised laser hair removal: case report and literature review. Can Fam Physician 2009; 55: 50–2.
- 8Bodendorf MO, Grunewald S, Paasch U. Epilationslaser. KVM, Berlin, 2013.
- 9Hammes S, Kimmig W. [Side effects and complications of therapy with laser and intense light sources]. Hautarzt 2013; 64: 145–54.
- 10Omi T. Static and dynamic modes of 810 nm diode laser hair removal compared: A clinical and histological study. Laser Ther 2017; 26: 31–7.
- 11Li W, Liu C, Chen Z et al. Safety and efficacy of low fluence, high repetition rate versus high fluence, low repetition rate 810-nm diode laser for axillary hair removal in Chinese women. J Cosmet Laser Ther 2016; 1–4.
- 12John H, Manoloudakis N, Stephen SJ. A systematic review of the use of lasers for the treatment of hidradenitis suppurativa. J. Plast Reconstr Aesthet Surg 2016; 69: 1374–81.
- 13Paul A, Kranz G, Schindl A et al. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis. Lasers Surg Med 2010; 42: 211–4.
- 14Vissing AC, Taudorf EH, Haak CS et al. Adjuvant eflornithine to maintain IPL-induced hair reduction in women with facial hirsutism: a randomized controlled trial. J Eur Acad Dermatol Venereol 2016; 30: 314–9.
- 15Lapidoth M, Dierickx C, Lanigan S et al. Best practice options for hair removal in patients with unwanted facial hair using combination therapy with laser: guidelines drawn up by an expert working group. Dermatology 2010; 221: 34–42.
- 16Hodson DS. Current and future trends in home laser devices. Semin Cutan Med Surg 2008; 27: 292–300.
- 17Thaysen-Petersen D, Erlendsson AM, Nash JF et al. Side effects from intense pulsed light: Importance of skin pigmentation, fluence level and ultraviolet radiation-A randomized controlled trial. Lasers Surg Med 2017; 49(1): 88–96.
- 18Chuang GS, Farinelli W, Christiani DC et al. Gaseous and particulate content of laser hair removal plume. JAMA Dermatol 2016; 152(12): 1320–6.
- 19Sammour R, Nasser S, Debahy N, El HC. Fox-Fordyce Disease: An under-diagnosed adverse event of laser hair removal? J Eur Acad Dermatol Venereol 2016; 30: 1578–82.
- 20Bodendorf MO, Grunewald S, Simon JC, Paasch U. Efficacy and cosmetic results of contact gel cooling of the skin during non-ablative laser procedures. J Dtsch Dermatol Ges 2008; 6: 647–52.
- 21Karsai S, Baumler W, Weiss C et al. Laser tattoo removal: do we already have picosecond lasers? J Dtsch Dermatol Ges 2018; 16(4): 468–70.
- 22Torbeck R, Bankowski R, Henize S, Saedi N. Lasers in tattoo and pigmentation control: role of the PicoSure® laser system. Med Devices (Auckl.) 2016; 9: 63–7.
- 23Chan JC, Shek SY, Kono T et al. A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians. Lasers Surg Med 2016; 48: 23–9.
- 24Brauer JA, Reddy KK, Anolik R et al. Successful and rapid treatment of blue and green tattoo pigment with a novel picosecond laser. Arch Dermatol 2012; 148: 820–3.
- 25Alabdulrazzaq H, Brauer JA, Bae YS, Geronemus RG. Clearance of yellow tattoo ink with a novel 532-nm picosecond laser. Lasers Surg Med 2015; 47: 285–8.
- 26Levin MK, Ng E, Bae YS et al. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review. Lasers Surg Med 2016; 48: 181–7.
- 27Friedman DJ. Successful treatment of a red and black Professional tattoo in skin type VI with a picosecond dual-wavelength, neodymium-doped yttrium aluminium garnet laser. Dermatol Surg 2016; 42: 1121–3.
- 28Lapidoth M, Aharonowitz G. Tattoo removal among Ethiopian Jews in Israel: tradition faces technology. J Am Acad Dermatol 2004; 51: 906–9.
- 29Pinto F, Grosse-Buning S, Karsai S et al. Nd:YAG (1064-nm) picosecond laser vs. Nd:YAG (1064-nm) nanosecond laser in tattoo removal: A randomized controlled single-blind clinical trial. Br J Dermatol 2017; 176(2): 457–64.
- 30Reiter O, Atzmony L, Akerman L et al. Picosecond lasers for tattoo removal: a systematic review. Lasers Med Sci 2016; 31: 1397–405.
- 31Kossida T, Rigopoulos D, Katsambas A, Anderson RR. Optimal tattoo removal in a single laser session based on the method of repeated exposures. J Am Acad Dermatol 2012; 66: 271–7.
- 32Schreiver I, Hutzler C, Laux P et al. Formation of highly toxic hydrogen cyanide upon ruby laser irradiation of the tattoo pigment phthalocyanine blue. Sci Rep 2015; 5: 12915.
- 33Hibler BP, Rossi AM. A case of delayed anaphylaxis after laser tattoo removal. JAAD Case Rep 2015; 1: 80–1.
- 34Yue B, Yang Q, Xu J, Lu Z. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients. Lasers Med Sci 2016; 31: 1657–63.
- 35Seitz AT, Grunewald S, Wagner JA et al. Fractional CO2 laser is as effective as Q-switched ruby laser for the initial treatment of a traumatic tattoo. J Cosmet Laser Ther 2014; 16: 303–5.
- 36Gupta AK, Versteeg SG. A critical review of improvement rates for laser therapy used to treat toenail onychomycosis. J Eur Acad Dermatol Venereol 2017; 31(7): 1111–8.
- 37Grunewald S, Bodendorf MO, Paasch U. Gefäßlaser. KVM, Berlin, 2012.
Citing Literature
